While there is currently no cure for multiple sclerosis, researchers continue to discover clues to give a better ...

Multiple sclerosis (MS) is a chronic inflammatory disorder that is thought to impact about 2.3 million people around the ...

When ocrelizumab became the first FDA-approved treatment for early forms of multiple sclerosis (MS) in 2017, it offered ...

AS a parent with a full-time job and a busy social life playing football and seeing friends, Adam Dawar always had somewhere ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Multiple Sclerosis, the most common neurological disorder in young adults, with symptoms usually occurring between the ages of 20 and 40 years. The r ...

Bruton tyrosine kinase (BTK) inhibitors are typically used to treat B-cell malignancies, but they have also recently attracted interest for their potential in treating the autoimmune disorder multiple ...

To evaluate whether a prodromal phase exists and, if so, identify the most common symptoms, claims from nationwide health insurance in Germany over a 10-year period (January 2010 to December 2020 ...

Multiple sclerosis (MS) is a chronic, immune-mediated and neurodegenerative disease characterised by the formation of destructive lesions predominantly involving myelinated axons within the central ...

Lyme disease, by contrast, tends to be concentrated in the Northeast, New England, and Great Lakes regions of the U.S. Lyme disease also tends to affect two main age groups, children and adults 40-50.

Managing the ups and downs of relapsing-remitting MS Last updated Jan. 15, 2025, by Marisa Wexler, MS Fact-checked by Inês Martins, PhD ...